The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
29
1kṀ5413
resolved Jan 25
Resolved
NO

Get
Ṁ1,000
to start trading!

🏅 Top traders

#NameTotal profit
1Ṁ304
2Ṁ148
3Ṁ81
4Ṁ31
5Ṁ28
Sort by:

We had a 3 mod panel with @CodeandSolder and @Ziddletwix on Discord.

There was a unanimous agreement to resolve no. We considered the warnings against compounded Semaglutide being potentially dangerous, but did not feel they met the criteria established in this market about overuse or misuse. They were more a general warning to be careful with these products in specific forms.

@CodeandSolder this feels like a judgement call situation to me. We probably need to do the 3 mod panel thing. Unless there are more warnings out there.

@KevinAugenstein This can resolve NO, thank you!

Does a warning about unlicensed versions count towards misuse? There's already blackmarket semaglutide available from Chinese chemical companies.

predictedNO

it needs to be specifically about semaglutide and the consequences of its use. Generic warnings about counterfeit production don’t count.

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules